This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
This meeting was held at Marriott's Desert Springs Resort, Palm Desert, Calif, April 29 and 30, 1995.
(1) Loren J. Bartels, MD, and Jonathan S. Sillman, MD, Tampa, Fla, described treating 29 patients with Meniere's disease with gentamicin administered to the transtympanic membrane. The authors reported 93% vertigo control with 78% complete absence of ice-water electronystagmographic caloric response during 6 month's followup. Twenty-four percent of patients required retreatment.
(3) Better results in treating patients with Meniere's disease may be obtained with dexamethasone applied to the transtympanic membrane, according to John J. Shea, MD, and his coworkers, Memphis, Tenn. The authors conducted an exhaustive literature search, which has suggested an autoimmune cause for Meniere's disease. Twenty-eight patients were treated with dexamethasone applied to the transtympanic membrane and oral steroids. The patients responded as follows: hearing improved in 42.9%, reduction
Lassen LF. Annual Meeting of the American Otological Society. Arch Otolaryngol Head Neck Surg. 1995;121(9):1066–1067. doi:10.1001/archotol.1995.01890090100022
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: